Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Developing Solutions for Docs to Interpret Life Tech MDx Test Data

NEW YORK (GenomeWeb News) – Ingenuity Systems today announced it is partnering with Life Technologies to develop a joint solution to help physicians interpret information from Life Tech's molecular diagnostic tests.

Ingenuity will provide its software and content to interpreting physicians, such as molecular pathologists and medical geneticists, in a dedicated portal so that they can review disease management guidelines, identify clinical trials, and find especially useful insights from biomedical research.

The solution will be provided "in context with other software and database solutions" so that physicians will have a range of information to decide on appropriate treatments or clinicals trial for patients, Ingenuity said.

The solution will initially be made available for Life Tech's cancer diagnostic tests.

Life Technologies Medical Sciences President Ronnie Andrews said that tests such as those being developed by the firm will deliver complex patient disease data, and "[i]t is essential that those results be made relevant to interpreting physicians by making all possible contextual information available in a single interpretation portal."

"With its broad technology platforms and targeted acquisitions Life Technologies is rapidly emerging as a leading provider of clinical diagnostic solutions," Jake Leschly, CEO of Ingenuity Systems, added. "Our unique content and applications address a critical bottleneck in the development of the clinical diagnostic market and our partnership with Life enables a unique and powerful end-to-end solution for the molecular pathologist."

Terms of the partnership were not disclosed.